Literature DB >> 28898457

Organic solute transporter-β (SLC51B) deficiency in two brothers with congenital diarrhea and features of cholestasis.

Mutaz Sultan1, Anuradha Rao2, Orly Elpeleg3, Frédéric M Vaz4, Bassam Abu-Libdeh1, Saul J Karpen2, Paul A Dawson2.   

Abstract

Primary bile acid malabsorption is associated with congenital diarrhea, steatorrhea, and a block in the intestinal return of bile acids in the enterohepatic circulation. Mutations in the ileal apical sodium-dependent bile acid transporter (ASBT; SLC10A2) can cause primary bile acid malabsorption but do not appear to account for most familial cases. Another major transporter involved in the intestinal reclamation of bile acids is the heteromeric organic solute transporter alpha-beta (OSTα-OSTβ; SLC51A-SLC51B), which exports bile acid across the basolateral membrane. Here we report the first patients with OSTβ deficiency, clinically characterized by chronic diarrhea, severe fat soluble vitamin deficiency, and features of cholestatic liver disease including elevated serum gamma-glutamyltransferase activity. Whole exome sequencing revealed a homozygous single nucleotide deletion in codon 27 of SLC51B, resulting in a frameshift and premature termination at codon 50. Functional studies in transfected cells showed that the SLC51B mutation resulted in markedly reduced taurocholic acid uptake activity and reduced expression of the OSTα partner protein.
CONCLUSION: The findings identify OSTβ deficiency as a cause of congenital chronic diarrhea with features of cholestatic liver disease. These studies underscore OSTα-OSTβ's key role in the enterohepatic circulation of bile acids in humans. (Hepatology 2017).
© 2017 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28898457      PMCID: PMC5847420          DOI: 10.1002/hep.29516

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  18 in total

Review 1.  Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics.

Authors:  Lynne E Maquat
Journal:  Nat Rev Mol Cell Biol       Date:  2004-02       Impact factor: 94.444

2.  β-Subunit of the Ostα-Ostβ organic solute transporter is required not only for heterodimerization and trafficking but also for function.

Authors:  Whitney V Christian; Na Li; Patricia M Hinkle; Nazzareno Ballatori
Journal:  J Biol Chem       Date:  2012-04-25       Impact factor: 5.157

3.  Mouse organic solute transporter alpha deficiency alters FGF15 expression and bile acid metabolism.

Authors:  Tian Lan; Anuradha Rao; Jamie Haywood; Nancy D Kock; Paul A Dawson
Journal:  J Hepatol       Date:  2012-04-25       Impact factor: 25.083

4.  The heteromeric organic solute transporter alpha-beta, Ostalpha-Ostbeta, is an ileal basolateral bile acid transporter.

Authors:  Paul A Dawson; Melissa Hubbert; Jamie Haywood; Ann L Craddock; Noa Zerangue; Whitney V Christian; Nazzareno Ballatori
Journal:  J Biol Chem       Date:  2004-11-24       Impact factor: 5.157

5.  Global functions of extracellular, transmembrane and cytoplasmic domains of organic solute transporter β-subunit.

Authors:  Whitney V Christian; Patricia M Hinkle
Journal:  Biochem J       Date:  2017-05-25       Impact factor: 3.857

6.  The organic solute transporter alpha-beta, Ostalpha-Ostbeta, is essential for intestinal bile acid transport and homeostasis.

Authors:  Anuradha Rao; Jamie Haywood; Ann L Craddock; Martin G Belinsky; Gary D Kruh; Paul A Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-21       Impact factor: 11.205

7.  Targeted deletion of the ileal bile acid transporter eliminates enterohepatic cycling of bile acids in mice.

Authors:  Paul A Dawson; Jamie Haywood; Ann L Craddock; Martha Wilson; Mary Tietjen; Kimberly Kluckman; Nobuyo Maeda; John S Parks
Journal:  J Biol Chem       Date:  2003-06-20       Impact factor: 5.157

Review 8.  Bile acid metabolism: relationship of bile acid malabsorption and diarrhea.

Authors:  W F Balistreri; J E Heubi; F J Suchy
Journal:  J Pediatr Gastroenterol Nutr       Date:  1983       Impact factor: 2.839

Review 9.  Congenital diarrhoeal disorders: advances in this evolving web of inherited enteropathies.

Authors:  Roberto Berni Canani; Giuseppe Castaldo; Rosa Bacchetta; Martín G Martín; Olivier Goulet
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-17       Impact factor: 73.082

Review 10.  The Farnesoid X Receptor: Good for BAD.

Authors:  Stephen J Keely; Julian R F Walters
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2016-08-29
View more
  20 in total

Review 1.  Intestinal Absorption of Bile Acids in Health and Disease.

Authors:  Alexander L Ticho; Pooja Malhotra; Pradeep K Dudeja; Ravinder K Gill; Waddah A Alrefai
Journal:  Compr Physiol       Date:  2019-12-18       Impact factor: 9.090

Review 2.  Animal models to study bile acid metabolism.

Authors:  Jianing Li; Paul A Dawson
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-05-18       Impact factor: 5.187

3.  Contributions of bile acids to gastrointestinal physiology as receptor agonists and modifiers of ion channels.

Authors:  Stephen J Keely; Andreacarola Urso; Alexandr V Ilyaskin; Christoph Korbmacher; Nigel W Bunnett; Daniel P Poole; Simona E Carbone
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2021-11-10       Impact factor: 4.052

4.  Role of Organic Solute Transporter Alpha/Beta in Hepatotoxic Bile Acid Transport and Drug Interactions.

Authors:  James J Beaudoin; Jacqueline Bezençon; Noora Sjöstedt; John K Fallon; Kim L R Brouwer
Journal:  Toxicol Sci       Date:  2020-07-01       Impact factor: 4.849

5.  Novel in Vitro Method Reveals Drugs That Inhibit Organic Solute Transporter Alpha/Beta (OSTα/β).

Authors:  Melina M Malinen; Antti Kauttonen; James J Beaudoin; Noora Sjöstedt; Paavo Honkakoski; Kim L R Brouwer
Journal:  Mol Pharm       Date:  2018-12-14       Impact factor: 4.939

Review 6.  Novel insights into the organic solute transporter alpha/beta, OSTα/β: From the bench to the bedside.

Authors:  James J Beaudoin; Kim L R Brouwer; Melina M Malinen
Journal:  Pharmacol Ther       Date:  2020-04-02       Impact factor: 12.310

7.  Farnesoid X Receptor Agonists Obeticholic Acid and Chenodeoxycholic Acid Increase Bile Acid Efflux in Sandwich-Cultured Human Hepatocytes: Functional Evidence and Mechanisms.

Authors:  Cen Guo; Carl LaCerte; Jeffrey E Edwards; Kenneth R Brouwer; Kim L R Brouwer
Journal:  J Pharmacol Exp Ther       Date:  2018-02-27       Impact factor: 4.030

Review 8.  The role of bile acids in cholestatic liver injury.

Authors:  Shi-Ying Cai; James L Boyer
Journal:  Ann Transl Med       Date:  2021-04

9.  Organic Solute Transporter Alpha Deficiency: A Disorder With Cholestasis, Liver Fibrosis, and Congenital Diarrhea.

Authors:  Emily Gao; Huma Cheema; Nadia Waheed; Iqra Mushtaq; Nihan Erden; Carol Nelson-Williams; Dhanpat Jain; Carol J Soroka; James L Boyer; Youssef Khalil; Peter T Clayton; Pramod K Mistry; Richard P Lifton; Sílvia Vilarinho
Journal:  Hepatology       Date:  2020-05       Impact factor: 17.298

Review 10.  Targeting the Four Pillars of Enterohepatic Bile Salt Cycling; Lessons From Genetics and Pharmacology.

Authors:  Roni F Kunst; Henkjan J Verkade; Ronald P J Oude Elferink; Stan F J van de Graaf
Journal:  Hepatology       Date:  2021-05-24       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.